secwatch.observer — SEC 8-K summary
======================================

Issuer:     OCTAVE SPECIALTY GROUP INC (OSG)
CIK:        0000874501
Form:       8-K
Filed at:   2025-05-12T23:59:59+00:00
Accession:  0000874501-25-000084
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ambac Q1 revenue up 27% to $63M but net loss widens; adjusted EBITDA negative
-----------------------------------------------------------------------------

- Total P&C premium production up 70% to $318M; revenue from continuing ops $63M (+27% YoY).
- Net loss from continuing ops attributable to shareholders of $16.1M vs $4.1M loss in Q1'24.
- Diluted EPS from continuing ops loss of $1.22 vs prior year EPS of $0.44 gain.
- Adjusted EBITDA to shareholders negative $1.3M vs positive $0.4M; Cirrata segment adjusted EBITDA up 136%.
- Legacy business sale pending only Wisconsin regulatory approval; discontinued ops net loss of $30.2M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/874501/000087450125000084/0000874501-25-000084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/874501/000087450125000084/ambc-20250512.htm
  HTML page:      https://secwatch.observer/filing/0000874501-25-000084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer